Literature DB >> 22907579

[Molecular signaling pathways. Mechanisms and clinical use].

N Cordes1, F Rödel, H-P Rodemann.   

Abstract

This brief summary on the role of experimental radiation oncology highlights several new research topics and research approaches that offer great potential for the optimization of modern radiation oncology. In addition, many areas of research, such as hypoxia, angiogenesis, the immune system, and metabolism, to name a few, comprise a substantial part of our current knowledge of tumor and radiation biology. Which new insights and therapeutic possibilities via the Human Cancer Genome Project or new processes, such as next generation sequencing may offer, cannot be easily foreseen at present. However, we do know for certain: radiation biology has and will continue to contribute to improvements in radiation oncology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907579     DOI: 10.1007/s00066-012-0205-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.

Authors:  Gianmaria Liccardi; John A Hartley; Daniel Hochhauser
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

2.  Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.

Authors:  Klaus Dittmann; Claus Mayer; Birgit Fehrenbacher; Martin Schaller; Uma Raju; Luka Milas; David J Chen; Rainer Kehlbach; H Peter Rodemann
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

3.  Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures.

Authors:  Iris Eke; Nils Cordes
Journal:  Radiother Oncol       Date:  2011-06-23       Impact factor: 6.280

4.  Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Authors:  Anjali K Gupta; W Gillies McKenna; Charles N Weber; Michael D Feldman; Jeffrey D Goldsmith; Rosemarie Mick; Mitchell Machtay; David I Rosenthal; Vincent J Bakanauskas; George J Cerniglia; Eric J Bernhard; Randal S Weber; Ruth J Muschel
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

Review 5.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

6.  Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro.

Authors:  Nils Cordes; Viktor Meineke
Journal:  Strahlenther Onkol       Date:  2003-05       Impact factor: 3.621

7.  Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.

Authors:  Nils Cordes; Christina Beinke; Ludwig Plasswilm; Dirk van Beuningen
Journal:  Strahlenther Onkol       Date:  2004-03       Impact factor: 3.621

8.  Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor.

Authors:  Claus Rödel; Joachim Haas; Anke Groth; Gerhard G Grabenbauer; Rolf Sauer; Franz Rödel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

Review 9.  Radiation-induced EGFR-signaling and control of DNA-damage repair.

Authors:  H Peter Rodemann; Klaus Dittmann; Mahmoud Toulany
Journal:  Int J Radiat Biol       Date:  2007 Nov-Dec       Impact factor: 2.694

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  6 in total

1.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

Review 2.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

3.  Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.

Authors:  Georgios Lazaridis; Sofia Lambaki; Georgia Karayannopoulou; Anastasia G Eleftheraki; Irene Papaspirou; Mattheos Bobos; Ioannis Efstratiou; George Pentheroudakis; Nikolaos Zamboglou; George Fountzilas
Journal:  Strahlenther Onkol       Date:  2014-07       Impact factor: 3.621

4.  Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.

Authors:  E-M Thurner; S Krenn-Pilko; U Langsenlehner; W Renner; A Gerger; K S Kapp; T Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

5.  Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.

Authors:  Yu-Hsuan Chen; Shiow-Lin Pan; Jing-Chi Wang; Sung-Hsin Kuo; Jason Chia-Hsien Cheng; Che-Ming Teng
Journal:  Strahlenther Onkol       Date:  2014-07-03       Impact factor: 3.621

6.  In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer.

Authors:  Deyou Tao; Junqing Liang; Yihong Pan; Yanting Zhou; Ying Feng; Lin Zhang; Jingjing Xu; Hui Wang; Ping He; Jie Yao; Yang Zhao; Qinjie Ning; Wen Wang; Wei Jiang; Jing Zheng; Xia Wu
Journal:  J Breast Cancer       Date:  2019-09-27       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.